When private equity installs the executive who already helped sell one skincare brand to L’Oréal, the assignment is not subtle. Orange County’s quietest hot sector just made its loudest hire.
Cellese, the Irvine-based regenerative aesthetics company behind the AnteAGE brand, appointed Christopher Hausman as Chief Executive Officer in June 2026, per the company’s announcement. Hausman brings more than three decades of experience building and scaling high-growth companies across aesthetics, dental, and healthcare, including a seat on the original SkinCeuticals leadership team, where he helped guide the brand through its acquisition by L’Oréal, one of the defining exits in modern professional skincare.
The company he inherits has real science underneath the shine. Founded in 2009, Cellese pioneered regenerative aesthetics with its AnteAGE line, built around growth factor technology and sold through aesthetic providers rather than department store counters. That provider-channel model matters: it means the company’s growth engine is relationships with physicians, medspas, and clinicians, exactly the channel Hausman spent his SkinCeuticals years mastering. Per the company, his mandate centers on expanding AnteAGE, deepening relationships with aesthetic providers, and advancing new regenerative skincare technologies.
The ownership context is the story under the story. Cellese was acquired in 2024 by ARCHIMED, a global private equity firm specializing exclusively in healthcare. PE firms do not hire caretakers; they hire operators with a proven playbook for the exact outcome they want, and a CEO whose resume includes a strategic exit to the world’s largest beauty company is about as legible as playbooks get. It is the same private-capital logic reshaping ownership across the region that we mapped in our Quiet Money report: when the check writers specialize, their talent demands specialize too.
Zoom out and you will find one of the sharpest executive markets nobody talks about. Orange County has quietly become a national hub for medical aesthetics and regenerative science, with device makers, skincare brands, and clinical innovators clustered from Irvine to Newport Beach. PE money keeps arriving with talent demands attached: commercial leaders who know the provider channel, regulatory-fluent operators, and executives who have actually scaled a brand to exit. That profile is scarce, and as our SoCal talent brief keeps showing, scarce profiles set the market for everyone else.
Expect hiring ripples across the sector. When a PE-backed platform brings in a scale-and-exit CEO, commercial, marketing, and R&D leadership upgrades usually follow within two quarters, and competitors start writing retention checks the same month. Watch the trends, and if you lead talent at an aesthetics company anywhere in the county, consider this your friendly warning to know who on your bench is now being called, because they are.
To Christopher Hausman: congratulations. Round two of building a category-defining skincare company starts now, this time from Irvine, and the whole sector will be watching how fast the playbook runs.
There is also a science-credibility angle worth watching. Regenerative aesthetics sits at the intersection of consumer beauty and clinical evidence, and the brands that win the next decade will be the ones providers actually trust in front of patients. That makes the sector’s executive hires unusually consequential: a CEO who can speak to both a dermatologist’s standards and a private equity board’s growth model is carrying two languages most operators never learn. Hausman built his career translating between exactly those rooms.
What to watch next: the pace of AnteAGE’s provider-channel expansion, any move into adjacent clinical categories, and the commercial leadership hires that typically follow a PE-installed CEO within two quarters. Aesthetics is one of Orange County’s most quietly competitive talent markets, and every move at the top resets the market beneath it. We will log each one on the People Moves Tracker, because in this sector, the org chart is the strategy.
A closing note on the ownership model, because it matters for candidates weighing offers in this sector. Specialist healthcare PE firms like ARCHIMED bring more than capital; they bring pattern recognition from dozens of portfolio companies, and they measure leadership in outcomes, not optics. Executives who thrive under that ownership tend to be the ones who like scoreboards. If that describes you, Orange County aesthetics is currently one of the most opportunity-dense markets in the country, and the bar for what counts as a serious operator just moved up.
Know a leader who deserves this spotlight?
This is what we do at Recruiter Hustle: we don’t just report the move, we honor the person behind it. If you, your company, or someone you admire just stepped into a new chapter, we want to tell that story right.
→ Submit a People Move • or reach out to Cathy Trinh directly, and let’s put your name in the light.
HEART. HUMAN. HUSTLE.
Sources & verification
Appointment & career detail: Cellese press release, June 2026, per the company’s announcement
Chief Talent Strategist & Editor-in-Chief | 26-year global recruiting veteran, #1 bestselling author, cancer survivor & humanitarian. Founder of Recruiter Hustle, OC/LA's no-filter media platform for talent, finance & recruiting professionals. Heart. Human. Hustle.